Your Life’s Path has been named a Wiley Platinum Award-winning Partner for 2024 and 2025. The award recognizes Your Life’s Path as a top global provider of workplace training solutions using Wiley ...
Beverly Hills spine surgeon and principal investigator will present pooled clinical outcomes following recent FDA ...
Personality tests are widely used in workplaces to shape recruitment, leadership training and team building. But what if artificial intelligence could make them faster, smarter and more accurate? New ...
Can AI predict your personality? New research shows machine learning can deliver DISC assessments 4x faster and with 93% accuracy. Learn how data science is identifying "hybrid" personality types and ...
Personality tests are widely used in workplaces to shape recruitment, leadership training and team building. But what if ...
Disc Medicine develops novel therapeutics targeting hematologic diseases, with a pipeline focused on red blood cell biology, heme biosynthesis, and iron homeostasis. The company operates a ...
A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...
I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...
Feb 17 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Tuesday it will pursue a traditional U.S. approval pathway for its rare disease drug after the Food and Drug Administration declined to ...
The FDA in October 2025 granted bitopertin its Commissioner’s National Priority Voucher but after a shortened review time has decided the data did not support regulatory approval for treating ...
The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that had been granted expedited review through a newly launched priority voucher program. While the agency agreed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results